Australia: The Trustees of the University of Pennsylvania, Novartis Receive Patent for 'Treatment of cancer using anti-CD19 chimeric antigen receptor'

Press/Media

PeriodOct 22 2021

Media coverage

1

Media coverage

  • TitleAustralia: The Trustees of the University of Pennsylvania, Novartis Receive Patent for 'Treatment of cancer using anti-CD19 chimeric antigen receptor'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date10/22/21
    PersonsMariusz A. Wasik